Author: OurCrowd

[MeMed in Startup News] Beckman Coulter and MeMed extend partnership advancing host immune response diagnostics

May 7, 2024 |

Beckman Coulter Diagnostics, a global leader in clinical diagnostics, and MeMed, a leader in the emerging field of advanced host-response technologies, today announced expansion of their host immune response diagnostics partnership. Beckman Coulter is now an authorized distributor of the MeMed BV® assay, a rapid immunoassay test able to distinguish between bacterial and viral infections, and MeMed Key®, a compact immunoassay analyzer cleared to run the MeMed BV assay in the United States and Europe. This new distribution agreement complements the existing joint effort to develop a MeMed BV-based test for Beckman Coulter’s family of Access Immunoassay Analyzers. Read more...

Read More

[Stellar Cyber in BusinessWire] Stellar Cyber to Unveil Gen AI Capabilities for Award-Winning Open XDR Platform and More at RSA Conference

May 6, 2024 |

Stellar Cyber, the innovator of Open XDR technology, will premiere a new set of capabilities in its SecOps platform at the RSA Conference this week in San Francisco, highlighted by the debut of its Gen AI-powered Open XDR Investigator. Stellar Cyber has won numerous awards for its Open XDR platform since it debuted at RSA in 2018, and will add to its record as a multiple winner of Global InfoSec awards for the fourth year in a row during a ceremony today at the conference. Read more...

Read More